controlled by a series of reactions by which the fatty acid (FA) It has been proposed that the ω-6 fatty acids increase the is released from membrane phospholipids by phospholipase A 2 rate of tumor growth. Here we test that hypothesis in the (PLA 2 ) and esterified in the phospholipids by acyltransferases.
PC-3 human prostate tumor. We found that the essential
Since cellular AA is almost exclusively sequestered in phosphofatty acids, linoleic acid (LA) and arachidonic acid (AA), lipids, the availability of this fatty acid is important for the and the AA metabolite PGE 2 stimulate tumor growth while synthesis of PGs. There are two primary means by which oleic acid (OA) and the ω-3 fatty acid, eicosapentaenoic cells can acquire AA: (i) from AA-albumin complex that is acid (EPA) inhibited growth. In examining the role of AA distributed freely in serum (5) , and (ii) from serum lipoprotein, in growth response, we extended our studies to analyze which sequesters unsaturated fatty acids, and is taken up by changes in early gene expression induced by AA. We the cell through a low density lipoprotein receptor (LDLr)-demonstrate that c-fos expression is increased within mediated mechanism (6). Habenicht and co-workers proposed minutes of addition in a dose-dependent manner. Moreover, that AA originates from LDL cholesteryl esters and can be the immediate early gene cox-2 is also increased in the metabolized by a variety of enzymes including COX and presence of AA in a dose-dependent manner, while the lipoxygenase (LOX) into PGs, TXs, and leukotrienes (LTs), constitutive cox-1 message was not increased. Three hours respectively (6-9). after exposure to AA, the synthesis of PGE 2 via COX- 2 Epidemiological, animal and cell studies have linked the was also increased. Previous studies have demonstrated essential fatty acids with prostate tumor growth (10-13). There that AA was primarily delivered by low density lipoprotein is evidence of a positive correlation between the levels of (LDL) via its receptor (LDLr). Since it is known that LDL and cancer cell growth. Studies by Bayerdorffer et that the up-regulation of cox-2 in colorectal tumors is co-PGE 2 synthesis, no change was seen in regulation of the regulated with LDLr expression in human tumor biopsies and LDLr by LDL. Taken together, these data show that normal cholesterol feedback of ldlr message and protein is lost in human tumor cells (16). Low sera cholesterol has long been prostate cancer. These data suggest that unregulated overassociated with increased cancer morbidity (20). To say that expression of LDLr in tumor cells would permit increased low cholesterol is a risk factor for cancer is in conflict with availability of AA, which induces immediate early genes data from Japanese studies where subjects had lower plasma c-fos and cox-2 within minutes of uptake. cholesterol level and a low incidence of many cancers. Moreover, patients on drugs that lower endogenous cholesterol synthesis show no increased incidence of cancer, despite the Introduction lowering of sera cholesterol (21) . This dichotomy may be explained by studies which demonstrated that lower cholesterol Essential fatty acids (EFA) and their products (including is not a risk factor, but rather a consequence of the tumor. In prostaglandins) have been implicated in upregulation of tumor a prospective study of 25 patients with colorectal carcinoma, cell growth (1, 2) . Prostaglandins (PGs) are short-lived and act individual shifts of sera cholesterol after surgery were measin an autocrine or paracrine manner to convey their biological ured. There was a significant rise in plasma cholesterol levels effects during cell growth, differentiation or inflammation.
in patients after curative surgery, but not after non-curative surgery. Since an elevated level of LDL receptor was found in the human prostate cancer cell line PC-3 (22). A second tumor growth.
Significance: *P Ͻ 0.05, **P Ͻ 0.001 when compared with controls.
Materials and methods

Measurement of DiI-LDL uptake
Quantification of DiI-LDL uptake was performed based on the analysis LDL isolated from human plasma was purchased from Sigma Chemical (St previously described (22, 23 
LDL and essential fatty acids accelerate growth of PC-3 cells
were grown in the same media supplemented with glucose (25 mM) and
To investigate the effect of LDL on cell growth and PGE 2 pyruvate (1 mM). Cells were maintained at high density in a 37°C incubator synthesis in prostate cancer cells, PC-3 cells were grown in with 5% CO 2 and fed three times a week. Twenty-four hours prior to cell platings; cell stocks were fed with fresh 10% FCS-containing medium. medium containing LPDS in the presence or absence of DmPGE 2 was used since this PGE 2 analog is a stable compound with the exogenous LDL. Table I shows that addition of exogenous equivalent biological activity. Longer incubation of native PGE 2 results in the LDL (8 µg/ml) increases cell growth 37% and increases breakdown of the compound and therefore the use of a stable analog is cellular PGE 2 almost 2-fold during the 36 h treatment period.
necessary for long periods of incubations. A side benefit of using dmPGE 2 is that subsequent analysis of newly synthesized PGE 2 can be made on these Because essential fatty acids carried by LDL are hypothesized cells since dmPGE 2 is not detected by the assay. Eicosanoids were made fresh to be responsible for increased PGE 2 synthesis and cell growth, as stocks in 10 mg/ml ethanol; in some cases they were stored at -20°C under we also tested the effect of AA treatment on these two oxygen-free conditions. Cells were down-regulated for 24 h in 2% FCS MEM parameters. AA alone stimulated growth almost 2-fold and media with 1.25 mg/ml albumin with additional 25 mM glucose and 1 mM increased PGE 2 synthesis 20-fold. 1 µg/ml AA. COX-2 activity (PGE 2 synthesis) was maximal in cells grown with a dose of 1-10 µg AA/ml.
Changes of LDLr mRNA levels in response to LDL and other exogenous factors
Reports have demonstrated a loss of cholesterol feedback in hepatomas (24) with later studies showing a lack of LDL receptor feedback regulation in colorectal cancer (16), acute myelogenous leukemia (18) and Burkitt's lymphoma (19). We suspected that prostate cancer cells also lacked a feedback regulation of LDLr by LDL, which could lead to increased uptake of LDL and subsequent cell growth. The effect of is shown in Figure 5A . We also used normal human fibroblasts in the same experiment as control. As expected, LDL had feedback regulation on LDLr mRNA expression in normal As seen in Table II , the amount of DiI-LDL uptake by cells as measured by spectrofluorometry did not vary significantly cells ( Figure 5B ).
Since FCS and PGE 2 upregulate cox-2 expression, we in cells grown in LPDS in the absence or presence of exogenously administered LDL. This result was confirmed by asked if they also regulate LDLr expression. Varying FCS concentrations (2 versus 10%) were added to PC-3 cells and examining the localization of uptake of fluorescent DiI-LDL in the cells under the fluorescent microscope. As seen in the expression analyzed using RT-PCR ( Figure 6 ). There was no significant difference in the levels of LDLr mRNA from cells photographs in Figure 7 , visualization of DiI-LDL uptake is comparable in both treatment groups, i.e. in medium with grown in either 2% FCS-(lane 1) or 10% FCS-containing medium (lane 4), indicating that higher concentrations of LPDS in the presence or absence of LDL for 36 h. These results indicate that the LDLr protein is functional, and that it serum lipoprotein did not downregulate LDLr mRNA expression. Long-term (18 h) and short-term (3 h) effect of administrais not feedback regulated by exogenous lipoprotein in PC-3 cells. In contrast, addition of exogenous LDL down-regulated tion of exogenous dmPGE 2 on LDLr expression was also investigated. As shown in Figure 6 , no significant changes in LDL uptake in normal human fibroblasts grown in LPDS. LDLr mRNA levels were seen with either long-or short-term dmPGE 2 administration. Taken together, these data suggest Discussion that LDLr mRNA expression in PC-3 is not feedback regulated Our long-term interest in finding a biochemical link between by LDL or by the growth stimulator and FA metabolite, PGE 2 . cellular fatty acids and cancer was renewed by the observation LDL uptake by PC-3 cells is not regulated by LDL that exogenous LDL is able to deliver AA for prostaglandin and leukotriene synthesis (9). Previous reports on PGE 2 upregFluorescent-labeled DiI-LDL was used as a measurement of LDL uptake by LDLr protein as described previously (22,23) .
ulation of prostate cancer growth and cox-2 mRNA synthesis Fig. 3 . Arachidonic acid upregulation of cox-2 mRNA. Cells were grown in 2% FCS media for 24 h before addition of AA. AA was added at varying LPDS 3.10 Ϯ 0.98 concentrations (0.1, 0.5, or 5 µg/ml). RNA was collected 2 h after addition LPDS ϩ LDL 2.33 Ϯ 0.81 of treatment and analyzed by RT-PCR as described in Materials and methods section. The figure is a representative of three separate PC-3 cells were seeded in 96-well plates and grown 24 h in LPDS before experiments.
measurement of functional LDLr. DiI-LDL in equal molar of LDL was added to both treatment groups for a 30 min incubation, excess label was rinsed off before fluorometric measurement (n ϭ 6).
cyclooxygenase upregulation. Since submission of this manuscript, two other reports have been published that supported our hypothesis that cyclooxygenase 2 plays a major role in prostate cancer (3, 4) . The data presented here show that essential fatty acids act like growth factors in stimulating growth of human prostate tumor PC-3 cells. The data also demonstrate that the PC-3 cells lack feedback regulation of LDLr mRNA expression and protein synthesis. We demonstrated in this study that LDL increased cell growth and PGE 2 synthesis in PC-3 cells. Since LDL delivers essential fatty acids to the cells, we next examined the effect finding shows that an increase in available FA energy source is not necessarily the cause of increased growth since media for all cells was supplemented with excess glucose and pyruvate. This finding also suggests a specific role for the essential fatty acids LA and AA. In unpublished data not shown here, non-steroidal anti-inflammatory compounds inhibit cell growth when added with AA or PGE 2 suggesting that AA growth induction may be working through a cyclooxygenase product.
We also examined the effect of increasing concentrations of AA on growth-related gene expression in the PC-3 cell. AA induced c-fos within 30 min of addition to the cell in a dose to PPARs; however, there is only one peroxisome proliferator inary mutation analysis on the PC-3 ldlr promoter region -307 to -30 using SSCP did not reveal the presence of a receptor element (PPRE) consensus, AA(t)C(g)TA(g)GGT(g), which resides approximately -3900 bases upstream of the coxmutation in the ldlr promoter region of PC-3 cells (data not shown). In examining other possibilities, although the rate of 2 promoter (28). The CRE element found in the first 200 proximal base pairs of both the c-fos and cox-2 promoter LDL internalization is similar to that described in other cells (24,25), it is possible that the post-endocytosis processing of regions is a strong candidate as a key element for up-regulation of message since this laboratory has recently shown that PGE 2 the LDLr protein is regulated differently in these cancer cells. Recent discovery of 25-hydroxycholesterol-resistant mutant induces CAT reporter with as little as the first proximal 99 base pairs of the promoter, which contains the CRE (29) . In cells which exhibits constitutive overexpression of ldlr and 3-hydroxy-3-methylglutaryl coenzyme A synthase genes has addition, recent findings show that prostate tissue and prostate tumors exclusively express the EP4 receptor (23).
also been reported (32) . These cells are unable to suppress transcription of ldlr even when cellular sterol levels are greatly Normal regulation of LDLr mRNA expression involves a negative feedback by sterols, which repress the transcription elevated. The cells also express a mutant form of SREBP-2 whose sequence is terminated at residue 460, producing a rate of the ldlr gene, via the sterol regulatory element (SRE-1) which is composed of three imperfect repeats (30, 31) . In constitutively active factor that is not inhibited by sterols. PC-3 cells may express such a mutant SREBP-2 form, which addition, LDL message is regulated differently in many cells by a variety of hormones or growth factors. For example, could explain the lack of regulation of ldlr mRNA expression. This possibility is currently under investigation. A publication transforming growth factor β significantly increases the binding, uptake and degradation of LDL, which is paralleled from this laboratory reports that SREBP-2 is not feedback regulated in prostate tumors (33) . by an increase in LDLr mRNA levels. Our results presented in Figures 5, 6 and 7 suggest that in PC-3 tumor cells, LDLr Our finding that cyclooxygenase 2 is upregulated in prostate and other cancers (16,22,23) and the findings of others that mRNA is not regulated by exogenous LDL or by dmPGE 2 , which is known to stimulate growth and cox-2 in these cells. cyclooxygenase 2 is upregulated in a majority of prostate cancers (3, 4) is in some conflict with the work of Ghosh and This laboratory is currently investigating the regulation of the LDLr in other prostate tumors and tissues, as well as the Myers (34,35) who reported a prominent role of 5-lipoxygenase in prostate cancers. It is possible that both the cyclooxygenases mechanism that causes the lack of feedback regulation. Prelim- growth by the ω-3 PUFAs is mediated through a decrease in
